Sanofi SA's Fiscal Year is From January To December - All Figures are in EUR, Billions.
The item "Selling-General-and-Administrative" stands at 10.26 Billion Euros for the trailing twelve months (TTM) period ending 09/30/2025.
Sanofi SA's third quarter result of 2.29 Billion EUR for the item "Selling General and Administrative" represents a decrease of -49.16 percent compared to it's second quarter result.
Also, Sanofi SA's third quarter result of 2.29 Billion EUR for the item "Selling General and Administrative" represents a decrease of -14.55 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Sanofi SA's third quarter result of 10.26 Billion EUR for the item "Selling General and Administrative" represents a decrease of -3.66 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -5.62 percent compared to the value the year prior.
The 1 year change in percent is -5.62.
The 3 year change in percent is -0.9078.
The 5 year change in percent is 37.49.
The 10 year change in percent is -6.11.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Selling General and Administrative | 905,699,262,464.00 |
![]() | Johnson & Johnson - Selling General and Administrative | 486,508,953,600.00 |
![]() | AbbVie Inc - Selling General and Administrative | 399,570,305,024.00 |
![]() | Roche Holding AG - Selling General and Administrative | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Selling General and Administrative | 280,205,508,085.11 |